Samplix
_42P5265_low.png

News

Follow Our News Section

 

News

January 1st, 2019: Samplix wins €1.9 million in prestigious Horizon 2020 – SME Instrument program

Today, Samplix announced that the company has been selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop™ technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%.

Samplix’ proprietary Xdrop™ technology comprises novel microfluidics, chemistry and bioinformatics in a simple work process that allows scientists and clinicians to partition millions of single molecules in droplets, thereby enabling both targeted enrichment and high-quality amplification of single molecules for sequencing analysis.

 The Xdrop™ technology is currently in beta test at leading research institutions world-wide.

 “We are excited to receive recognition and support by the European Commission for completion of our product development towards commercial launch of the Xdrop™ solution later this year” said CEO Lars Kongsbak.

Samplix business.png

February 27-March 2, 2019:

Samplix participates in the AGBT conference in Orlando Florida. Looking forward to seeing you at our posters!

AGBT_WebsiteFinal-01-e1464105889100.png

February 12-15, 2018:

Samplix participates in the AGBT conference in Orlando Florida. Looking forward to seeing you at posters 606 and 618

AGBT_GM2018-e1501086039968.png

May 27-30, 2017:

 Samplix participates in the European Society for Human Genetics conference, Copenhagen, Denmark.

ESHG.png

March, 2017:

Samplix participates in the VIB Next generation Sequencing Technologies conference in Leuven, Belgium.

Next gen sequencing.png

January 20, 2017:

Samplix and partners to receive close to 1 million € in public funding through the Eurostars progam.

The DNANext project including Samplix and four European partners has been earmarked for funding through the Eurostars program for development and testing of new technology for high quality DNA analysis.

Eurostars is a joint programme between EUREKA and the European Commission, co-funded from the national budgets of 36 Eurostars Participating States and Partner Countries and by the European Union through Horizon 2020. Eurostars supports international innovative projects led by R&D-performing small- and medium-sized enterprises.


September 26-28, 2016:

Samplix participates in the 4th Annual MedTech & Digital Health and 16th Annual Biotech in Europe Forum in Basel.


Sachs.png
Next generation.png

December 11, 2015:

Samplix was among the top 25 Award Winners of the European Venture Contest 2015.

EVC2015-AwardWinners_Medium.jpg